studyId: syn53604892 studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment initiative: Other fundingAgency: Other
Drop files to upload
mqc_fastp-seq-quality-plot_Read_2_After_filtering.svg page is loading…